Literature DB >> 9510864

Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage.

L K Lewis1, M W Smith, T G Yandle, A M Richards, M G Nicholls.   

Abstract

We describe a specific and sensitive RIA for human adrenomedullin (AM)(1-52). The detection limit and the concentration required for 50% inhibition of binding were 0.1 and 1.2 fmol/tube, respectively. Cross-reactivities with AM(1-12), AM(13-52), calcitonin gene-related peptide, amylin, and other vasoactive hormones were negligible. AM immunoreactivity in normal subjects ranged from 2.7 to 10.1 pmol/L (n = 44). We investigated factors influencing the recovery and measurement of AM in the assay. Recovery of labeled AM (> 80%) was markedly higher than that of unlabeled AM (56%). Immunoreactivity of exogenous AM added to plasma decreased up to 70% over four freeze-thaw cycles, whereas endogenous AM was stable. Alkali-treated casein (1 g/L) reduced adsorption of AM to surfaces and significantly increased assay precision compared with bovine serum albumin (P < 0.0001). HPLC separation of extracted plasma verified the presence of AM(1-52). We suggest that considerable care is needed to ensure that accurate and reproducible results are obtained from studies quantifying this peptide.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510864

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

Review 1.  Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?

Authors:  Mihael Potocki; Ronny Ziller; Christian Mueller
Journal:  Curr Heart Fail Rep       Date:  2012-09

Review 2.  Novel neurohumoral factors in congestive heart failure: adrenomedullin.

Authors:  J G Lainchbury
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

3.  Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure.

Authors:  Andras Iring; Young-June Jin; Julián Albarrán-Juárez; Mauro Siragusa; ShengPeng Wang; Péter T Dancs; Akiko Nakayama; Sarah Tonack; Min Chen; Carsten Künne; Anna M Sokol; Stefan Günther; Alfredo Martínez; Ingrid Fleming; Nina Wettschureck; Johannes Graumann; Lee S Weinstein; Stefan Offermanns
Journal:  J Clin Invest       Date:  2019-06-17       Impact factor: 14.808

4.  Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction.

Authors:  C M Yu; B M Cheung; R Leung; Q Wang; W H Lai; C P Lau
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

5.  Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure.

Authors:  C H Strey; J M Young; J H Lainchbury; C M Frampton; M G Nicholls; A M Richards; R S Scott
Journal:  Heart       Date:  2006-05-18       Impact factor: 5.994

Review 6.  New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failure.

Authors:  Francisco Valenzuela-Sánchez; Blanca Valenzuela-Méndez; Juan Francisco Rodríguez-Gutiérrez; Ángel Estella-García; María Ángela González-García
Journal:  Ann Transl Med       Date:  2016-09

7.  Circulating Adrenomedullin Is Elevated in Gestational Diabetes and Its Role in Impaired Insulin Production by β-Cells.

Authors:  Yuanlin Dong; Manu Banadakoppa; Madhu Chauhan; Meena Balakrishnan; Michael Belfort; Chandra Yallampalli
Journal:  J Clin Endocrinol Metab       Date:  2019-03-01       Impact factor: 5.958

8.  The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort.

Authors:  Ghazaleh Gouya; Gisela Sturm; Claudia Lamina; Emanuel Zitt; Otto Freistätter; Joachim Struck; Michael Wolzt; Florian Knoll; Friederike Lins; Karl Lhotta; Ulrich Neyer; Florian Kronenberg
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

9.  Adrenomedullin concentrations at two time points following myocardial infarction and prediction of mid-term outcomes.

Authors:  Zofia Dzielińska; Lukasz A Małek; Andrzej Januszewicz; Aleksander Prejbisz; Jerzy Pręgowski; Paweł Tyczyński; Magdalena Makowiecka-Cieśla; Jadwiga Janas; Marcin Demkow; Witold Ruzyłło
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

10.  Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis.

Authors:  Rossella Marino; Joachim Struck; Alan S Maisel; Laura Magrini; Andreas Bergmann; Salvatore Di Somma
Journal:  Crit Care       Date:  2014-02-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.